| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 0 | 0 | 0 | 162.550 | 33.097 | 185.798 | 82.514 | 4.803 |
| Total Income - EUR | - | 0 | 34 | 891 | 191 | 170.152 | 40.360 | 186.019 | 89.447 | 4.948 |
| Total Expenses - EUR | - | 183 | 3.484 | 6.758 | 3.195 | 97.936 | 32.935 | 98.848 | 156.508 | 218.716 |
| Gross Profit/Loss - EUR | - | -183 | -3.450 | -5.867 | -3.004 | 72.216 | 7.425 | 87.171 | -67.061 | -213.768 |
| Net Profit/Loss - EUR | - | -183 | -3.450 | -5.881 | -3.004 | 67.653 | 6.670 | 85.096 | -67.766 | -213.817 |
| Employees | - | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 1 |
Check the financial reports for the company - Biotech Industries S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 444 | 242 | 47 | 37 | 0 | 1.208.739 | 1.566.720 | 2.172.680 |
| Current Assets | - | 217 | 890 | 3.585 | 1.510 | 162.220 | 180.074 | 237.876 | 281.022 | 524.257 |
| Inventories | - | 0 | 0 | 0 | 0 | 145.133 | 165.935 | 166.675 | 170.790 | 178.286 |
| Receivables | - | 0 | 317 | 497 | 577 | 15.563 | 13.876 | 42.221 | 104.520 | 299.751 |
| Cash | - | 217 | 573 | 3.088 | 933 | 1.524 | 263 | 28.980 | 5.711 | 46.220 |
| Shareholders Funds | - | 39 | -3.411 | -9.229 | -12.054 | 55.859 | 60.813 | 146.270 | 78.061 | -136.193 |
| Social Capital | - | 223 | 219 | 215 | 211 | 238 | 232 | 406 | 404 | 402 |
| Debts | - | 178 | 29.535 | 38.138 | 38.209 | 130.529 | 170.151 | 1.339.124 | 1.800.198 | 2.856.788 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5210 - 5210" | |||||||||
| CAEN Financial Year |
2020
|
|||||||||
Comments - Biotech Industries S.r.l.